The retail pharmacy giant reported $1.22 earnings per share versus an expected $1.03 and revenue of $36.31 billion versus an expected $34.95.
Walgreens said its pharmacy sales grew as it filled more prescriptions and gave more flu shots, CNBC reported. Pharmacy sales rose 5 percent over last year, but the company also saw less foot traffic, lower sales of cough, cold and flu medications and fewer new prescriptions.
Walgreens shares have fallen about 28 percent in the last year, bringing its market value to $37.2 billion, according to CNBC.
Read the full article here.
More articles on pharmacy:
CVS names first chief customer officer
AmerisourceBergen to buy Walgreens’ Alliance Healthcare for $6.5B
Up to 6,000 pharmacies could begin giving COVID-19 vaccines in 2 weeks, HHS official says
